176 related articles for article (PubMed ID: 3724068)
1. Measurement of flecainide plasma concentrations by high performance liquid chromatography with fluorescence detection.
Plomp TA; Boom HT; Maes RA
J Anal Toxicol; 1986; 10(3):102-6. PubMed ID: 3724068
[TBL] [Abstract][Full Text] [Related]
2. High-performance liquid chromatographic method for the simultaneous determination of pentisomide and its major metabolite N-desisopropylpentisomide in plasma, urine and tissues using solid-phase extraction.
Plomp TA; Buijs MJ
J Chromatogr; 1993 Jan; 612(1):123-35. PubMed ID: 8454692
[TBL] [Abstract][Full Text] [Related]
3. Application of a bonded-phase extraction column for rapid sample preparation of flecainide from human plasma for high-performance liquid chromatographic analysis--fluorescence or ultraviolet detection.
Chang SF; Miller AM; Fox JM; Welscher TM
Ther Drug Monit; 1984; 6(1):105-11. PubMed ID: 6710553
[TBL] [Abstract][Full Text] [Related]
4. High-performance liquid chromatographic method for the quantitation of flecainide, a new antiarrhythmic, in human plasma and urine.
Chang SF; Welscher TM; Miller AM; Ober RE
J Chromatogr; 1983 Feb; 272(2):341-50. PubMed ID: 6833431
[TBL] [Abstract][Full Text] [Related]
5. High performance liquid chromatography for routine monitoring of serum flecainide.
Nakagawa R; Homma M; Kuga K; Yamaguchi I; Kobayashi D; Morimoto Y; Kohda Y
J Pharm Biomed Anal; 2002 Aug; 30(1):171-4. PubMed ID: 12151077
[TBL] [Abstract][Full Text] [Related]
6. Determination of concentrations of flecainide in human serum by high-performance liquid chromatography on a fluorocarbon-bonded silica gel column.
Obayashi M; Kosugi T; Yamazaki J; Matsumoto Y; Fukuoka M; Matsumoto M
J Chromatogr B Biomed Sci Appl; 1999 Apr; 726(1-2):219-23. PubMed ID: 10348189
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of amiodarone and its major metabolite desethylamiodarone in plasma, urine and tissues by high-performance liquid chromatography.
Plomp TA; Engels M; Robles de Medina EO; Maes RA
J Chromatogr; 1983 Apr; 273(2):379-92. PubMed ID: 6863450
[TBL] [Abstract][Full Text] [Related]
8. [Determination of the concentration of a new antiarrhythmic, flecainide, in plasma using high pressure liquid chromatography (HPLC): sample preparation with extraction columns].
Becker JU
J Clin Chem Clin Biochem; 1984 May; 22(5):389-93. PubMed ID: 6470629
[TBL] [Abstract][Full Text] [Related]
9. Improved solid-phase extraction technique for plasma flecainide analysis by high-performance liquid chromatography.
Wilson KM; Schneider JJ; Ravenscroft PJ
Ther Drug Monit; 1998 Aug; 20(4):435-8. PubMed ID: 9712470
[TBL] [Abstract][Full Text] [Related]
10. High-performance liquid chromatographic method for the quantitation of a meta-O-dealkylated metabolite of flecainide acetate, a new antiarrhythmic.
Chang SF; Welscher TM; Miller AM; McQuinn RL; Fox JM
J Chromatogr; 1985 Sep; 343(1):119-27. PubMed ID: 4066846
[TBL] [Abstract][Full Text] [Related]
11. Analysis of cisapride in neonatal plasma using high-performance liquid chromatography with a base-stable column and fluorescence detection.
Preechagoon Y; Charles BG
J Chromatogr B Biomed Appl; 1995 Aug; 670(1):139-43. PubMed ID: 7493071
[TBL] [Abstract][Full Text] [Related]
12. Validation of an ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of flecainide in human plasma and its clinical application.
Mano Y; Asakawa Y; Kita K; Ishii T; Hotta K; Kusano K
Biomed Chromatogr; 2015 Sep; 29(9):1399-405. PubMed ID: 25641720
[TBL] [Abstract][Full Text] [Related]
13. Improved high-performance liquid chromatographic assay for the determination of procainamide and its N-acetylated metabolite in plasma: application to a single-dose pharmacokinetic study.
Lessard E; Fortin A; Coquet A; Bélanger PM; Hamelin BA; Turgeon J
J Chromatogr Sci; 1998 Jan; 36(1):49-54. PubMed ID: 9443381
[TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatographic determination of 12 antiarrhythmic drugs in plasma using solid-phase column extraction.
Verbesselt R; Tjandramaga TB; De Schepper PJ
Ther Drug Monit; 1991 Mar; 13(2):157-65. PubMed ID: 2053124
[TBL] [Abstract][Full Text] [Related]
15. A simple high-performance liquid chromatographic method for the routine measurement of flecainide in plasma.
Grgurinovich N
J Anal Toxicol; 1988; 12(1):38-41. PubMed ID: 3127637
[TBL] [Abstract][Full Text] [Related]
16. A high performance liquid chromatographic method for the quantitation of flecainide in plasma.
Broly F; Marecaux P; Houdret N; Lhermitte M; Houssin R
Biomed Chromatogr; 1991 Nov; 5(6):248-50. PubMed ID: 1760591
[TBL] [Abstract][Full Text] [Related]
17. High-performance liquid chromatographic assay for sematilide in plasma using solid-phase extraction microcolumn technology.
Laganière S; Goernert L; Beatch G
J Chromatogr B Biomed Appl; 1994 Oct; 660(1):191-5. PubMed ID: 7858714
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring of flecainide in serum using high-performance liquid chromatography and electrospray mass spectrometry.
Breindahl T
J Chromatogr B Biomed Sci Appl; 2000 Sep; 746(2):249-54. PubMed ID: 11076078
[TBL] [Abstract][Full Text] [Related]
19. High-performance liquid chromatographic method for the measurement of mexiletine and flecainide in blood plasma or serum.
Bhamra RK; Flanagan RJ; Holt DW
J Chromatogr; 1984 May; 307(2):439-44. PubMed ID: 6736191
[No Abstract] [Full Text] [Related]
20. Small blood volumes from children for quantitative sotalol determination using high-performance liquid chromatography.
Läer S; Wauer I; Scholz H
J Chromatogr B Biomed Sci Appl; 2001 Apr; 753(2):421-5. PubMed ID: 11334359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
